Trials / Completed
CompletedNCT02642679
Evaluation of Opticell Ag on Split-Thickness Skin Graft Donor Sites in Adult Subjects
Evaluation of Opticell Ag (Chitosan Based Dressing) on Split-Thickness Skin Graft (STSG) Donor Sites in Adult Subjects
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 19 (actual)
- Sponsor
- Brigham and Women's Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this single center, prospective case series is to evaluate the effective management of split-thickness skin graft donor site wounds using Opticell Ag (Chitosan-based dressing).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Opticell Ag | Opticell Ag+ applied to STSG donor site |
Timeline
- Start date
- 2016-01-01
- Primary completion
- 2016-10-01
- Completion
- 2016-12-01
- First posted
- 2015-12-30
- Last updated
- 2017-12-08
- Results posted
- 2017-12-08
Source: ClinicalTrials.gov record NCT02642679. Inclusion in this directory is not an endorsement.